VEGFA and breast carcinoma: These MDA-MB-231-secreted EVs enhanced the production of neutrophil extracellular traps, interleukin (IL)-8, and VEGF from N2 neutrophils, as well as increased the expression of Arg-1, MMP9, and the N2 neutrophil marker CD184, which subsequently promoted breast cancer cell invasion (87).